Birdwatch Note Rating
2023-05-24 16:20:44 UTC - HELPFUL
Rated by Participant: EE3E0D301A7AF26EA01A4FF54D8C807FACBADEE851369CD22A1BB382CD7C90E3
Participant Details
Original Note:
Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation. WHO now suggests the use of Remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details